Evidence map›Paper›PMID 42288367›Full record

ReviewSeminars in radiation oncology2026

Herbal Products and Dietary Supplements in Radiation Oncology: Evidence, Safety, and Practical Patient Counseling.

Yen-Nien Hou, Jyothirmai Gubili, Jun J Mao

Abstract readReview
In one paragraph

Review in Seminars in radiation oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Yen-Nien HouDepartment of Medicine, Memorial Sloan Kettering Cancer Center, Integrative Medicine and Wellness Service, New York, NY.. Electronic address: houy@mskcc.org.
Jyothirmai GubiliDepartment of Medicine, Memorial Sloan Kettering Cancer Center, Integrative Medicine and Wellness Service, New York, NY.
Jun J MaoDepartment of Medicine, Memorial Sloan Kettering Cancer Center, Integrative Medicine and Wellness Service, New York, NY.

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI SELWYN M VICKERS · 1985 to 2026
$347.4M
NCI NIH HHS P30 CA008748
6 · The paper itself

Abstract

Studies show that patients with cancer use herbal products more often than the general population. Lowering the risk of disease recurrence, symptom control, and improving quality of life are often the reasons cited for such use. However, a major concern is that few patients communicate with their oncology providers about such use. Although herbal products are perceived as natural and safe, they can lead to adverse effects and interact with prescription medications, including cancer treatments. Herb-drug interactions can render some treatments less effective or potentiate adverse effects of others. Therefore, patient-physician communication is critical to guide safe and appropriate use of herbal products and to minimize potential harm. The About Herbs website, developed and maintained by the Integrative Medicine and Wellness Service at Memorial Sloan Kettering Cancer Center, contains up-to-date, evidence-based information on purported uses, adverse effects and herb-drug interactions for 317 and growing number of herbs, vitamins, and other dietary supplements. The 5 most frequently accessed entries in 2025 were ashwagandha, Boswellia, active hexose correlated compound, reishi mushroom, and turmeric. In this article, we describe their uses and current evidence of effectiveness in oncology settings including radiation treatment.

Indexed as

Dietary SupplementsNeoplasmsPhytotherapyPlant PreparationsRadiation OncologyCounselingHerb-Drug InteractionsHumansPlant Preparations

Identifiers

PMID42288367
PMCPMC13346417

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.